Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Bacterial Vaccines Market Segmentation
1. Executive Summary
2. Global Bacterial Vaccines Market Introduction
2.1. Global Bacterial Vaccines Market - Taxonomy
2.2. Global Bacterial Vaccines Market - Definitions
2.2.1. Vaccine Type
2.2.2. Indication
2.2.3. Age Group
2.2.4. Route of Administration
2.2.5. Region
3. Global Bacterial Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
3.6. Epidemiology
3.7. Pipeline Analysis
4. Global Bacterial Vaccines Market By Vaccine Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
4.1. Live Attenuated Vaccines
4.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3. Market Opportunity Analysis
4.2. Inactivated Vaccines
4.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3. Market Opportunity Analysis
4.3. Conjugate Vaccines
4.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3.3. Market Opportunity Analysis
4.4. Toxoid Vaccines
4.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.4.3. Market Opportunity Analysis
4.5. Others
4.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.5.3. Market Opportunity Analysis
5. Global Bacterial Vaccines Market By Indication, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Pertussis
5 1 1 Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Tetanus
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Diphtheria
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Pneumococcal
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Meningococcal
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Typhoid
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Tuberculosis
5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Cholera
5.8.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Shigellosis
5.9.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
5.10. Others
5.10.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.10.3. Market Opportunity Analysis
6. Global Bacterial Vaccines Market By Age Group, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Pediatric
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Adolescent
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Adults
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Geriatric
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Bacterial Vaccines Market By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Oral
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Parenteral
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Bacterial Vaccines Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. MEA
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. North America Bacterial Vaccines Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Vaccine Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.1.1. Live Attenuated Vaccines
9.1.2. Inactivated Vaccines
9.1.3. Conjugate Vaccines
9.1.4. Toxoid Vaccines
9.1.5. Others
9.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.2.1. Pertussis
9.2.2. Tetanus
9.2.3. Diphtheria
9.2.4. Pneumococcal
9.2.5. Meningococcal
9.2.6. Typhoid
9.2.7. Tuberculosis
9.2.8. Cholera
9.2.9. Shigellosis
9.2.10. Others
9.3. Age Group Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.3.1. Pediatric
9.3.2. Adolescent
9.3.3. Adults
9.3.4. Geriatric
9.4. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.4.1. Oral
9.4.2. Parenteral
9.4.3. Others
9.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.5.1. USA
9.5.2. Canada
10. Europe Bacterial Vaccines Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Vaccine Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1. Live Attenuated Vaccines
10.1.2. Inactivated Vaccines
10.1.3. Conjugate Vaccines
10.1.4. Toxoid Vaccines
10.1.5. Others
10.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1. Pertussis
10.2.2. Tetanus
10.2.3. Diphtheria
10.2.4. Pneumococcal
10.2.5. Meningococcal
10.2.6. Typhoid
10.2.7. Tuberculosis
10.2.8. Cholera
10.2.9. Shigellosis
10.2.10. Others
10.3. Age Group Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1. Pediatric
10.3.2. Adolescent
10.3.3. Adults
10.3.4. Geriatric
10.4. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.4.1. Oral
10.4.2. Parenteral
10.4.3. Others
10.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.5.1. Germany
10.5.2. France
10.5.3. Italy
10.5.4. Spain
10.5.5. UK
10.5.6. Rest of Europe
11. Asia Pacific Bacterial Vaccines Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Vaccine Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1. Live Attenuated Vaccines
11.1.2. Inactivated Vaccines
11.1.3. Conjugate Vaccines
11.1.4. Toxoid Vaccines
11.1.5. Others
11.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1. Pertussis
11.2.2. Tetanus
11.2.3. Diphtheria
11.2.4. Pneumococcal
11.2.5. Meningococcal
11.2.6. Typhoid
11.2.7. Tuberculosis
11.2.8. Cholera
11.2.9. Shigellosis
11.2.10. Others
11.3. Age Group Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1. Pediatric
11.3.2. Adolescent
11.3.3. Adults
11.3.4. Geriatric
11.4. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.4.1. Oral
11.4.2. Parenteral
11.4.3. Others
11.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.5.1. China
11.5.2. Japan
11.5.3. South Korea
11.5.4. India
11.5.5. Rest of APAC
12. Latin America Bacterial Vaccines Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Vaccine Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.1.1. Live Attenuated Vaccines
12.1.2. Inactivated Vaccines
12.1.3. Conjugate Vaccines
12.1.4. Toxoid Vaccines
12.1.5. Others
12.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.2.1. Pertussis
12.2.2. Tetanus
12.2.3. Diphtheria
12.2.4. Pneumococcal
12.2.5. Meningococcal
12.2.6. Typhoid
12.2.7. Tuberculosis
12.2.8. Cholera
12.2.9. Shigellosis
12.2.10. Others
12.3. Age Group Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.3.1. Pediatric
12.3.2. Adolescent
12.3.3. Adults
12.3.4. Geriatric
12.4. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.4.1. Oral
12.4.2. Parenteral
12.4.3. Others
12.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Argentina
12.5.4. Rest of Latin America
13. MEA Bacterial Vaccines Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Vaccine Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.1.1. Live Attenuated Vaccines
13.1.2. Inactivated Vaccines
13.1.3. Conjugate Vaccines
13.1.4. Toxoid Vaccines
13.1.5. Others
13.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.2.1. Pertussis
13.2.2. Tetanus
13.2.3. Diphtheria
13.2.4. Pneumococcal
13.2.5. Meningococcal
13.2.6. Typhoid
13.2.7. Tuberculosis
13.2.8. Cholera
13.2.9. Shigellosis
13.2.10. Others
13.3. Age Group Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.3.1. Pediatric
13.3.2. Adolescent
13.3.3. Adults
13.3.4. Geriatric
13.4. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.4.1. Oral
13.4.2. Parenteral
13.4.3. Others
13.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of MEA
14. Global Chronic Kidney Disease Treatment - Pipeline Drug Analysis
14.1. Global Chronic Kidney Disease Treatment Disease Epidemiology
14.2.Global Chronic Kidney Disease Treatment , Pipeline Drugs Assessment
14.3. Global Chronic Kidney Disease Treatment , Pipeline Drugs Assessment - Sponsors/Companies
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Biological E Limited
15.2.2. Serum Institute of India
15.2.3. Bavarian Nordic A/S
15.2.4. GlaxoSmithKline plc
15.2.5. Bavarian Nordic A/S
15.2.6. Pfizer, Inc.
15.2.7. Merck & Co, Inc.
15.2.8. Sanofi S.A
15.2.9. Bharat Biotech
15.2.10. AstraZeneca plc
16. Research Methodology
17. Key Assumptions and Acronyms
2. Global Bacterial Vaccines Market Introduction
2.1. Global Bacterial Vaccines Market - Taxonomy
2.2. Global Bacterial Vaccines Market - Definitions
2.2.1. Vaccine Type
2.2.2. Indication
2.2.3. Age Group
2.2.4. Route of Administration
2.2.5. Region
3. Global Bacterial Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
3.6. Epidemiology
3.7. Pipeline Analysis
4. Global Bacterial Vaccines Market By Vaccine Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
4.1. Live Attenuated Vaccines
4.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3. Market Opportunity Analysis
4.2. Inactivated Vaccines
4.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3. Market Opportunity Analysis
4.3. Conjugate Vaccines
4.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3.3. Market Opportunity Analysis
4.4. Toxoid Vaccines
4.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.4.3. Market Opportunity Analysis
4.5. Others
4.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.5.3. Market Opportunity Analysis
5. Global Bacterial Vaccines Market By Indication, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Pertussis
5 1 1 Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Tetanus
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Diphtheria
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Pneumococcal
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Meningococcal
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Typhoid
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Tuberculosis
5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Cholera
5.8.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Shigellosis
5.9.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
5.10. Others
5.10.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.10.3. Market Opportunity Analysis
6. Global Bacterial Vaccines Market By Age Group, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Pediatric
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Adolescent
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Adults
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Geriatric
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Bacterial Vaccines Market By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Oral
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Parenteral
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Bacterial Vaccines Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. MEA
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. North America Bacterial Vaccines Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Vaccine Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.1.1. Live Attenuated Vaccines
9.1.2. Inactivated Vaccines
9.1.3. Conjugate Vaccines
9.1.4. Toxoid Vaccines
9.1.5. Others
9.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.2.1. Pertussis
9.2.2. Tetanus
9.2.3. Diphtheria
9.2.4. Pneumococcal
9.2.5. Meningococcal
9.2.6. Typhoid
9.2.7. Tuberculosis
9.2.8. Cholera
9.2.9. Shigellosis
9.2.10. Others
9.3. Age Group Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.3.1. Pediatric
9.3.2. Adolescent
9.3.3. Adults
9.3.4. Geriatric
9.4. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.4.1. Oral
9.4.2. Parenteral
9.4.3. Others
9.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.5.1. USA
9.5.2. Canada
10. Europe Bacterial Vaccines Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Vaccine Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1. Live Attenuated Vaccines
10.1.2. Inactivated Vaccines
10.1.3. Conjugate Vaccines
10.1.4. Toxoid Vaccines
10.1.5. Others
10.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1. Pertussis
10.2.2. Tetanus
10.2.3. Diphtheria
10.2.4. Pneumococcal
10.2.5. Meningococcal
10.2.6. Typhoid
10.2.7. Tuberculosis
10.2.8. Cholera
10.2.9. Shigellosis
10.2.10. Others
10.3. Age Group Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1. Pediatric
10.3.2. Adolescent
10.3.3. Adults
10.3.4. Geriatric
10.4. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.4.1. Oral
10.4.2. Parenteral
10.4.3. Others
10.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.5.1. Germany
10.5.2. France
10.5.3. Italy
10.5.4. Spain
10.5.5. UK
10.5.6. Rest of Europe
11. Asia Pacific Bacterial Vaccines Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Vaccine Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1. Live Attenuated Vaccines
11.1.2. Inactivated Vaccines
11.1.3. Conjugate Vaccines
11.1.4. Toxoid Vaccines
11.1.5. Others
11.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1. Pertussis
11.2.2. Tetanus
11.2.3. Diphtheria
11.2.4. Pneumococcal
11.2.5. Meningococcal
11.2.6. Typhoid
11.2.7. Tuberculosis
11.2.8. Cholera
11.2.9. Shigellosis
11.2.10. Others
11.3. Age Group Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1. Pediatric
11.3.2. Adolescent
11.3.3. Adults
11.3.4. Geriatric
11.4. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.4.1. Oral
11.4.2. Parenteral
11.4.3. Others
11.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.5.1. China
11.5.2. Japan
11.5.3. South Korea
11.5.4. India
11.5.5. Rest of APAC
12. Latin America Bacterial Vaccines Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Vaccine Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.1.1. Live Attenuated Vaccines
12.1.2. Inactivated Vaccines
12.1.3. Conjugate Vaccines
12.1.4. Toxoid Vaccines
12.1.5. Others
12.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.2.1. Pertussis
12.2.2. Tetanus
12.2.3. Diphtheria
12.2.4. Pneumococcal
12.2.5. Meningococcal
12.2.6. Typhoid
12.2.7. Tuberculosis
12.2.8. Cholera
12.2.9. Shigellosis
12.2.10. Others
12.3. Age Group Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.3.1. Pediatric
12.3.2. Adolescent
12.3.3. Adults
12.3.4. Geriatric
12.4. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.4.1. Oral
12.4.2. Parenteral
12.4.3. Others
12.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Argentina
12.5.4. Rest of Latin America
13. MEA Bacterial Vaccines Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Vaccine Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.1.1. Live Attenuated Vaccines
13.1.2. Inactivated Vaccines
13.1.3. Conjugate Vaccines
13.1.4. Toxoid Vaccines
13.1.5. Others
13.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.2.1. Pertussis
13.2.2. Tetanus
13.2.3. Diphtheria
13.2.4. Pneumococcal
13.2.5. Meningococcal
13.2.6. Typhoid
13.2.7. Tuberculosis
13.2.8. Cholera
13.2.9. Shigellosis
13.2.10. Others
13.3. Age Group Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.3.1. Pediatric
13.3.2. Adolescent
13.3.3. Adults
13.3.4. Geriatric
13.4. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.4.1. Oral
13.4.2. Parenteral
13.4.3. Others
13.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of MEA
14. Global Chronic Kidney Disease Treatment - Pipeline Drug Analysis
14.1. Global Chronic Kidney Disease Treatment Disease Epidemiology
14.2.Global Chronic Kidney Disease Treatment , Pipeline Drugs Assessment
14.3. Global Chronic Kidney Disease Treatment , Pipeline Drugs Assessment - Sponsors/Companies
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Biological E Limited
15.2.2. Serum Institute of India
15.2.3. Bavarian Nordic A/S
15.2.4. GlaxoSmithKline plc
15.2.5. Bavarian Nordic A/S
15.2.6. Pfizer, Inc.
15.2.7. Merck & Co, Inc.
15.2.8. Sanofi S.A
15.2.9. Bharat Biotech
15.2.10. AstraZeneca plc
16. Research Methodology
17. Key Assumptions and Acronyms
• Biological E Limited
• Serum Institute of India
• Bavarian Nordic A/S
• GlaxoSmithKline plc
• Bavarian Nordic A/S
• Pfizer, Inc.
• Merck & Co, Inc.
• Sanofi S.A
• Bharat Biotech
• AstraZeneca plc
• Serum Institute of India
• Bavarian Nordic A/S
• GlaxoSmithKline plc
• Bavarian Nordic A/S
• Pfizer, Inc.
• Merck & Co, Inc.
• Sanofi S.A
• Bharat Biotech
• AstraZeneca plc